Beam Therapeutics Cash Flow Statement 2018-2024 | BEAM

Fifteen years of historical annual cash flow statements for Beam Therapeutics (BEAM).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-132.53$-289.09$-370.64$-194.59$-78.33$-116.74
$-9.73$4.74$7.38$4.85$2.58$0.65
$107$70.72$176$20.51$7.14$69.64
$97.77$75.46$183$25.37$9.72$70.29
$0$0$0$0$0$0
$0$0$0$0$0$0
$-7.58$2.37$0.82$0.06$4.09$2.44
$-174.52$251$76.51$66.39$-11.06$22.11
$-114.44$236$121$73.48$-3.40$26.15
$-149.20$22.53$-66.27$-95.74$-72.00$-20.30
$-33.73$-48.95$-46.81$-16.36$-12.52$-13.12
$0$0$0$0$0$0
$0$0$0.62$0$0$0
$0$0$0$0$0$0
$106$-412.39$-247.95$-83.77$-54.14$-0.30
$106$-412.39$-247.95$-83.77$-54.14$-0.30
$0$0$0$0$0$0
$71.84$-461.34$-294.14$-100.12$-66.66$-13.42
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$279$114$767$3.16$0.19$0.01
$279$114$767$3.16$38.09$180
$0$0$0$0$0$0
$-2.88$-2.48$-10.93$319$3.19$0
$276$112$756$322$41.28$180
$199$-327.22$396$126$-97.38$146
$98.65$84.32$43.57$15.38$7.03$7.00
$0$0$0$0$0$0